Dopamine produced from L-DOPA is degraded by endogenous monoamine oxidase in neurons of the dorsal raphe nucleus of the rat: An immunohistochemical study

Brain Research

Volumn 722, Issue 1-2, 1996, Pages 181-184

  Arai, Ryohachi ^a   Karasawa, Nobuyuki ^a   Nagatsu, Ikuko ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

dopamine; dorsal raphe nucleus; L DOPA; monoamine oxidase; pargyline; Parkinson's disease; rat; serotonin neuron

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); CARBIDOPA; DOPAMINE; LEVODOPA; PARGYLINE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG METABOLISM; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029996949     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00252-1     Document Type: Article

References (31)

1. Arai, R., Kimura, H. and Maeda, T., Topographic atlas of monoamine oxidase-containing neurons in the rat brain studied by an improved histochemical method, Neuroscience, 19 (1986) 905-925.
2. Arai, R., Karasawa, N., Geffard, M., Nagatsu, T. and Nagatsu, I., Immunohistochemical evidence that central serotonin neurons produce dopamine from exogenous L-dopa in the rat, with reference to the involvement of aromatic L-amino acid decarboxylase, Brain Res., 667 (1994) 295-299.
3. Arai, R., Karasawa, N., Geffard, M. and Nagatsu, I., L-dopa is converted to dopamine in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study, Neurosci. Lett., 195 (1995) 195-198.
4. Arai, R., Karasawa, N. and Nagatsu, I., Aromatic L-amino acid decarboxylase is present in serotonergic fibers of the striatum of the rat. A double-labeling immunofluorescence study, Brain Res., 706 (1996) 177-179.
5. Azzaro, A.J., King, J., Kotsuk, J., Schoepp, D.D., Frost, J. and Schochet, S., Guinea pig striatum as a model of human dopamine deamination: the role of monoamine oxidase isozyme ratio, localization, and affinity for substrate in synaptic dopamine metabolism, J. Neurochem., 45 (1985) 949-956.
6. Bartholini, G., Da Prada, M. and Pletscher, A., Decrease of cerebral 5-hydroxytryptamine by 3,4-dihydroxyphenylalanine after inhibition of extracerebral decarboxylase, J. Pharm. Pharmacol., 20 (1968) 228-229.
7. Berry, M.D., Juorio, A.V. and Paterson, I.A., Possible mechanisms of action of (-)deprenyl and other MAO-B inhibitors in some neurologic and psychiatric disorders, Prog. Neurobiol., 44 (1994) 141-161.
8. Brannan, T., Bhardwaj, A., Martinez-Tica, J., Weinberger, J. and Yahr, M., Striatal L-dopa metabolism studied in vivo in rats with nigrostriatal lesions, J. Neural Transm. (Park. Dis. Dement. Sect.), 2 (1990) 15-22.
9. Chagnaud, J.-L., Mons, N., Tuffet, S., Grandier-Vazeilles, X. and Geffard, M., Monoclonal antibodies against glutaraldehyde conjugated dopamine, J. Neurochem., 49 (1987) 487-494.
10. Ciliax, B.J., Heilman, C., Demchyshyn, L.L., Pristupa, Z.B., Ince, E., Hersch, S.M., Niznik, H.B. and Levey, A.I., The dopamine transporter: immunochemical characterization and localization in brain, J. Neurosci., 15 (1995) 1714-1723.
11. Everett, G.M. and Borcherding, J.W., L-dopa: effect on concentrations of dopamine, norepinephrine, and serotonin in brains of mice, Science, 168 (1970) 849-850.
12. Garrick, N.A. and Murphy, D.L., Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain, Psychopharmacology, 72 (1980) 27-33.
13. Glover, V., Sandler, M., Owen, F. and Riley, G.J., Dopamine is a monoamine oxidase B substrate in man, Nature, 265 (1977) 80-81.
14. Gershanik, O.S., Heikkila, R.E. and Duvoisin, R.C., The role of serotonin neurons in the action of L-dopa in an animal model of parkinsonism, Neurology, 29 (1979) 553.
15. Hornykiewicz, O., The mechanisms of action of L-dopa in Parkinson's disease, Life Sci., 15 (1974) 1249-1259.
16. Hsu, S.M., Raine, L. and Fanger, H., Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem., 29 (1981) 577-580.
17. Konradi, C., Svoma, E., Jellinger, K., Riederer, P., Denney, R. and Thibault, J., Topographic immunocytochemical mapping of monoamine oxidase-A, monoamine oxidase-B and tyrosine hydroxylase in human post mortem brain stem, Neuroscience, 26 (1988) 791-802.
18. Konradi, C., Kornhuber, J., Froelich, L., Fritze, J., Heinsen, H., Beckmann, H., Schulz, E. and Riederer, P., Demonstration of monoamine oxidase-A and -B in the human brainstem by a histochemical technique, Neuroscience, 33 (1989) 383-400.
19. Levitt, P., Pintar, J.E. and Breakefield, X.O., Immunocytochemical demonstration of monoamine oxidase B in brain astrocytes and serotonergic neurons, Proc. Natl. Acad. Sci. USA, 79 (1982) 6385-6389.
20. Maitre, L., Delini-Stura, A. and Waldmeier, P.C., Relations between the degree of monoamine oxidase inhibition and some psychopharmacological responses to monoamine oxidase inhibitors in rats, Ciba Foundation Symposium (new series), 39 (1976) 247-270.
21. Maeda., T., Imai, H., Arai, R., Tago, H., Nagai, T., Sakumoto, T., Kitahama, K., Onténiente, B. and Kimura, H., An improved coupled peroxidatic oxidation method of MAO histochemistry for neuroanatomical research at light and electron microscopic levels, Cell. Mol. Biol., 33 (1987) 1-11.
22. Ng, K.Y., Chase, T.N., Colburn, R.W. and Kopin, I.J., L-dopa-induced release of cerebral monoamines, Science, 170 (1970) 76-77.
23. B inhibitor Ro19-6327 potentiates the effects of levodopa on parkinsonism induced by MPTP in the common marmoset, Neuropharmacology, 32 (1993) 473-477.
24. Porter, C.C., Watson, L.S., Titus, D.C., Totara, J.A. and Byer, S.S., Inhibition of DOPA decarboxylase by the hydrazino analog of α-methyldopa, Biochem. Pharmacol., 11 (1962) 1067-1077.
25. Shimada, S., Kitayama, S., Walther, D. and Uhl, G., Dopamine transporter mRNA: dense expression in ventral midbrain neurons, Mol. Brain Res., 13 (1992) 359-362.
26. Steinbusch, H.W.M., Distribution of serotonin-immunoreactivity in the central nervous system of the rat-cell bodies and terminals, Neuroscience, 6 (1981) 557-618.
27. Takeuchi, Y., Kimura, H. and Sano, Y., Immunohistochemical demonstration of the distribution of serotonin neurons in the brainstem of the rat and cat, Cell Tiss. Res., 224 (1982) 247-267.
28. Yang, H.-Y.T. and Neff, N.H., The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines, J. Pharmacol. Exp. Ther., 189 (1974) 733-740.
29. Westlund, K.N, Denney, R.M., Kochersperger, L.M., Rose, R.M. and Abell, C.W., Distinct monoamine oxidase A and B cell populations in primate brain, Science, 230 (1985) 181-183.
30. Westlund, K.N., Denney, R.M., Rose, R.M. and Abell, C.W., Localization of distinct monoamine oxidase A and monoamine oxidase B cell populations in human brainstem, Neuroscience, 25 (1988) 439-456.
31. Willoughby, J., Glover, V. and Sandler, M., Histochemical localisation of monoamine oxidase A and B in rat brain, J. Neural Transm., 74 (1988) 29-42.